©The Author(s) 2025.
World J Gastroenterol. Sep 14, 2025; 31(34): 109825
Published online Sep 14, 2025. doi: 10.3748/wjg.v31.i34.109825
Published online Sep 14, 2025. doi: 10.3748/wjg.v31.i34.109825
Figure 1 B-cell CLL/Lymphoma 10 promotes the proliferation of colorectal cancer cells in vitro and in vivo.
A and B: Colony formation assays showing proliferation ability in SW480 and SW620 cell lines with BCL10 knockdown (SH-BCL10) or overexpression (OE-BCL10). NC1: Scrambled shRNA control; NC2: Empty vector control. cP < 0.001; C: Western blot analysis of MYC and Ki67 expression. bP < 0.01; cP < 0.001; D: Immunohistochemical staining of MYC and Ki67 in xenograft tumors. Scale bars: 50 μm (main panels, 20 × magnification); 20 μm (insets, 40 × magnification); E: EdU assay for cell proliferation detection. Scale bars: 50 μm.
- Citation: Xiao PT, Li CF, Liu YD, Zhong J, Cui XL, Liu C, Yang W. B cell CLL/lymphoma 10 promotes colorectal cancer cell proliferation and regulates cuproptosis sensitivity through the NF-κB signaling pathway. World J Gastroenterol 2025; 31(34): 109825
- URL: https://www.wjgnet.com/1007-9327/full/v31/i34/109825.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i34.109825